Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis

Table 2 Survival rate estimates of patients with EC by schedule of chemoradiotherapy

Schedule of CRT	Overall survival	No. of studies	No. of patients		OR (95% CI)	P
			CRT + S	S
Sequential	1 yr	3	237	234	1.12 (0.77, 1.64)	0.56
	3 yr	3	237	234	1.24 (0.82, 1.88)	0.31
	5 yr	2	191	188	1.24 (0.81, 1.91)	0.32
Concurrent	1 yr	6	352	343	1.41 (1.03, 1.94)	0.03
	3 yr	7	374	366	2.12 (1.20, 3.76)	0.011
	5 yr	5	265	261	1.72 (1.10, 2.71)	0.02

¹Random effects model was used. EC: Esophageal carcinoma; CRT + S: Neoadjuvant chemoradiotherapy and surgery; S: Surgery; OR: Odds ratio; CI: Confidence interval.